GleamWall
中文EN

TNDM TANDEM DIABETES CARE INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1438133 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.8%
TTM net income YoY75.8%
TTM EPS YoY76.4%
Revenue 3-yr CAGR11.7%
Net income 3-yr CAGR—

Margins

Gross margin56.6%
Operating margin-2.4%
Net margin-4.6%
FCF margin-3.4%
EBITDA margin-0.7%

Returns

ROE-36.7%
ROA-4.8%
ROIC (approx.)-3.9%
Asset turnover1.06x

Leverage & solvency

Liabilities / assets88.3%
Debt / equity4.47x
Current ratio3.21x
Interest coverage-2.80x

Cash quality & payout

Operating cash flow / net income0.30x
Accruals ratio-3.4%
Payout ratio—
Capex / revenue2.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.01B$940.20M
Cost of revenue$468.72M$450.63M
Gross profit$546.01M$489.57M
R&D expense$193.11M$198.88M
SG&A expense$444.99M$389.82M
Operating income-$187.26M-$99.13M
Interest expense$7.91M$7.42M
Pretax income-$200.27M-$91.87M
Income tax$4.44M$4.16M
Net income-$204.71M-$96.03M
EBITDA-$169.59M-$82.52M
EPS (basic)-3.04-1.47
EPS (diluted)-3.04-1.47
Weighted avg. shares (diluted)67.28M65.45M
Balance sheet
Cash & equivalents$90.63M$69.23M
Short-term investments$202.03M$369.10M
Receivables$165.49M$114.58M
Inventory$128.77M$149.61M
Current assets$618.14M$724.49M
PP&E, net$83.58M$78.15M
Intangibles$11.72M$925,000
Total assets$881.11M$967.66M
Current liabilities$242.72M$247.05M
Short-term debt—$40.67M
Long-term debt$310.04M$308.27M
Total debt$310.04M$348.94M
Total liabilities$725.94M$704.56M
Shareholders' equity$155.17M$263.10M
Net debt$219.40M$279.70M
Shares outstanding68.29M66.26M
Cash flow statement
Operating cash flow-$9.72M$24.23M
Capital expenditure$19.95M$19.23M
Free cash flow-$29.67M$4.99M
Investing cash flow$72.88M-$23.48M
Financing cash flow-$43.37M$8.37M
Depreciation & amortization$17.67M$16.61M
Stock-based compensation$92.38M$101.38M
Share buybacks$0$30.00M

Free plan shows the latest 2 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.